MDMA-Assisted Therapy in the Media
By Rachel Nuwer
May 3, 2021
The New York Times
By Maya Singer
February 12, 2021
VOGUE Magazine
"...MDMA—may help alleviate the isolation brought on by COVID. It may also play a role in helping the people hardest hit by the pandemic recuperate: Nautilus Sanctuary, a nonprofit psychedelics-research and training center in New York, is already planning a study exploring the use of MDMA to treat frontline workers with severe PTSD—one of the many inquiries to expand on the drug’s groundbreaking FDA trials sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS), which entered phase three in 2017."
Painting by Jeanette Mundt, My Lee Reynold’s Mushrooms, 2016, oil on canvas, 24 x 18 in.
Courtesy of the artist and The Green Gallery, Milwaukee.
MAPS' Phase III clinical trials using MDMA-assisted therapy for moderate to severe PTSD
Ongoing Study
MDMA-assisted therapy as a treatment for Post Traumatic Stress in COVID-19 Frontline Healthcare Workers
Upcoming Study
More News
The following content is presented by Google News with the search query "MDMA-Assisted Psychotherapy"
MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers
Nautilus Sanctuary receives FDA Approval for an Investigator-Initiated Clinical Trial in the use of MDMA-assisted therapy to treat symptoms of post-traumatic stress and burnout in NYC-area healthcare workers affected by their response to the COVID pandemic.